Enliven Therapeutics
ELVN
#3795
Rank
$3.62 B
Marketcap
$50.75
Share price
-0.20%
Change (1 day)
152.99%
Change (1 year)

Enliven Therapeutics (ELVN) - Total debt

Total debt on the balance sheet as of March 2026 : $0.3 Million USD

According to Enliven Therapeutics's latest financial reports the company's total debt is $0.3 Million USD. A companyโ€™s total debt is the sum of all current and non-current debts.

Enliven Therapeutics - Total debt on balance sheet (from 2021 to 2026)

Total debt by year

Year Total debt Change
2025-12-31$0.39 M
2024-12-31N/A-100%
2023-12-31$0.33 M3.72%
2022-12-31$0.32 M103.14%
2021-12-31$0.15 M51.43%
2020-12-31$0.1 M